Helen C Fox1, Eric D Jackson, Rajita Sinha. 1. Yale Stress Center, Department of Psychiatry, Yale University School of Medicine, 2 Church Street South, Suite 209, Room 209Q, New Haven, CT 06519, USA. helen.fox@yale.edu
Abstract
OBJECTIVE: Cocaine dependence is characterized by stress system dysregulation, including elevated cortisol activity, emotional negativity, and behavioral disinhibition. High levels of stress and glucocorticoids are also known to affect learning, memory and executive function. Therefore, we examined the relationships between chronic cocaine use, elevated distress and learning and memory dysfunction in abstinent cocaine dependent (CD) individuals, and whether these measures were associated with cocaine relapse outcomes. METHOD: Stress was assessed in 36 inpatient treatment engaged CD individuals and 36 demographically matched healthy control (HC) participants using the Perceived Stress Scale (PSS) and repeated morning salivary cortisol levels over three consecutive days. The Rey Auditory Verbal Learning Test (RAVLT) was conducted to measure verbal learning, memory, and executive function. Prospective assessment of cocaine use outcomes during 90 days following discharge from inpatient treatment was also conducted. RESULTS: CD patients showed higher levels of distress compared to controls in PSS scores and cortisol levels. They also demonstrated a significantly reduced learning curve, and fewer correct responses and more errors on recognition. Elevated cortisol was significantly associated with worse RAVLT performance in CD patients. Poor memory scores, but not distress measures, were significantly associated with greater cocaine use after inpatient treatment. CONCLUSIONS: These findings are the first to demonstrate that learning and memory deficits in CD individuals are associated with enhanced cortisol and with cocaine use outcomes after inpatient treatment. The findings are consistent with recent addiction models suggesting that chronic cocaine-related neuroadaptations affects learning and memory function, which in turn, influences drug use outcomes.
OBJECTIVE:Cocaine dependence is characterized by stress system dysregulation, including elevated cortisol activity, emotional negativity, and behavioral disinhibition. High levels of stress and glucocorticoids are also known to affect learning, memory and executive function. Therefore, we examined the relationships between chronic cocaine use, elevated distress and learning and memory dysfunction in abstinent cocaine dependent (CD) individuals, and whether these measures were associated with cocaine relapse outcomes. METHOD: Stress was assessed in 36 inpatient treatment engaged CD individuals and 36 demographically matched healthy control (HC) participants using the Perceived Stress Scale (PSS) and repeated morning salivary cortisol levels over three consecutive days. The Rey Auditory Verbal Learning Test (RAVLT) was conducted to measure verbal learning, memory, and executive function. Prospective assessment of cocaine use outcomes during 90 days following discharge from inpatient treatment was also conducted. RESULTS:CDpatients showed higher levels of distress compared to controls in PSS scores and cortisol levels. They also demonstrated a significantly reduced learning curve, and fewer correct responses and more errors on recognition. Elevated cortisol was significantly associated with worse RAVLT performance in CDpatients. Poor memory scores, but not distress measures, were significantly associated with greater cocaine use after inpatient treatment. CONCLUSIONS: These findings are the first to demonstrate that learning and memory deficits in CD individuals are associated with enhanced cortisol and with cocaine use outcomes after inpatient treatment. The findings are consistent with recent addiction models suggesting that chronic cocaine-related neuroadaptations affects learning and memory function, which in turn, influences drug use outcomes.
Authors: Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek Journal: Psychopharmacology (Berl) Date: 2003-07-04 Impact factor: 4.530
Authors: Ilana S Hairston; Milton T M Little; Michael D Scanlon; Monique T Barakat; Theo D Palmer; Robert M Sapolsky; H Craig Heller Journal: J Neurophysiol Date: 2005-07-13 Impact factor: 2.714
Authors: T Smeets; M Jelicic; H Merckelbach; M Peters; A Fett; J Taverniers; C Henquet; J Dautzenberg Journal: Behav Neurosci Date: 2006-12 Impact factor: 1.912
Authors: Helen C Fox; Kwangik A Hong; Prashni Paliwal; Peter T Morgan; Rajita Sinha Journal: Psychopharmacology (Berl) Date: 2007-09-21 Impact factor: 4.530
Authors: Vanessa J Meyer; Deborah M Little; Daniel A Fitzgerald; Erin E Sundermann; Leah H Rubin; Eileen M Martin; Kathleen M Weber; Mardge H Cohen; Pauline M Maki Journal: J Neurovirol Date: 2014-04-24 Impact factor: 2.643
Authors: Yan Zhou; Yoav Litvin; Anna Paola Piras; Donald W Pfaff; Mary Jeanne Kreek Journal: Neuropsychopharmacology Date: 2011-06-15 Impact factor: 7.853
Authors: Kathleen M Kantak; Nicole Barlow; David H Tassin; Madeline F Brisotti; Chloe J Jordan Journal: Psychopharmacology (Berl) Date: 2014-05-07 Impact factor: 4.530
Authors: Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold Journal: Postgrad Med Date: 2009-11 Impact factor: 3.840